5, PP 989-994 [online] Available at: (accessed 7 th April 2022) Gao, X., Sanderson, S.M., Dai, Z., Reid, M.A., Cooper, D.E., Lu, M., Richie, J.P., Ciccarella, A., Calcagnotto, A., Mikhael, P.G., Mentch, S.J., Liu, J., Ables, G., Kirsch, D.G., Hsu, D.S., Nichenametia, S.N
Critically, the STEP 4 trial showed that patients who discontinued semaglutide regained two-thirds of their lost weight within a year which has major implications for how you think about long-term access and cost sustainability
What STEP-1 Showed: Semaglutide's Impact on Lean Mass In the STEP-1 trial, participants on semaglutide 2.4 mg per week lost approximately 15% of total body weight over 68 weeks
Skin health: Glutathione has been shown to improve the appearance of skin by reducing the production of melanin, the pigment that causes dark spots
Precautions - Avoid contact with eyes